Jenoptik AG (JNPKF) reports a 50% surge in order intake and raises full-year 2026 guidance on robust semiconductor demand.

Jenoptik (ETR:JEN) reported a return to revenue growth and a sharp improvement in profitability in the first half of 2026, supported by demand in its semiconductor-focused operations and strong order activity in Biophotonics. The company also raised the specificity of its full-year outlook, forecast

Shareholders will be ecstatic, with their stake up 32% over the past week following Jenoptik AG 's ( ETR:JEN ) latest...

Jenoptik (ETR:JEN) highlighted its positioning as a photonics-focused supplier to semiconductor, medical and life science, metrology and smart mobility markets during a presentation at the digital German Select Conference, with Head of IR and Sustainability Andreas Theisen outlining 2025 performance

While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a significant share price rise of...

Jenoptik AG (JNPKF) navigates a complex market with strategic expansions and operational improvements, despite facing revenue declines in key sectors.

Jenoptik (ETR:JEN) management used its fiscal 2025 results call to outline progress on strategic initiatives, discuss a year shaped by a weaker semiconductor lithography environment, and provide guidance for a return to profitable growth in 2026. CFO Dr. Prisca Havranek-Kosicek was joined by Head of

Key Insights Institutions' substantial holdings in Jenoptik implies that they have significant influence over the...